<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487914</url>
  </required_header>
  <id_info>
    <org_study_id>386</org_study_id>
    <nct_id>NCT02487914</nct_id>
  </id_info>
  <brief_title>Evaluation of Pressure Sense Threshold and Tactile Sensation After Lidocaine Iontophoresis Using Interferential Current</brief_title>
  <official_title>Iontophoresis Effects on Senses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drug delivery is conducted through various methods such as injection, phonophoresis, and
      iontophoresis. Iontophoresis is defined as the noninvasive delivery of active ions through
      epidermis using direct current. The direct current has some disadvantages such as skin
      burning and limited time of application. Interferential current is a kind of alternating
      currents without limitations of direct current; so the purpose of this study was to
      investigate and compare the effects of Lidocaine, interferential current and Lidocaine
      iontophoresis using interferential current.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pressure, tactile, and pain thresholds were evaluated before and after the application of
      Lidocaine, interferential current and Lidocaine iontophoresis using interferential current.
      Pressure threshold was investigated with a Pesula. Pesula is a pen-like scaled mechanical
      device that measures the skin pressure threshold. Pesula was pressed to the skin and pressure
      threshold was measured in mm. Pain and tactile thresholds were investigated using an
      electrical stimulator.The intensity was gradually increased to the extent that the
      participant reported a tingling sensation. The displayed intensity was considered as the
      tactile sense threshold. Then, the intensity was increased to the extent to be intolerable
      for the participant and this intensity was considered as the maximum pain threshold. The
      thresholds were recorded in milliampere.

      Lidocaine iontophoresis using interferential current can increase perception threshold of
      pain, and pressure sense more significantly in comparison to the application of Lidocaine and
      interferential current alone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain threshold- evaluated by increasing intensity of interferential current.</measure>
    <time_frame>up to one week</time_frame>
    <description>pain threshold to increasing intensity of interferential current.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tactile threshold- evaluated by exact perception of the lowest level of interferential current</measure>
    <time_frame>up to one week</time_frame>
    <description>exact perception of the lowest level of interferential current</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pressure threshold- evaluated by Pesula</measure>
    <time_frame>up to one week</time_frame>
    <description>Pesula was used to evaluate tactile threshold.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Interferential Current Drug Delivery</condition>
  <arm_group>
    <arm_group_label>lidocaine iontophoresis using interferential current</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the threshold of pressure, tactile,and pain thresholds were evaluated after the iontophoresis of Lidocaine using interferential current.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>interferential current</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the threshold of pressure, tactile,and pain thresholds were evaluated after the application of interferential current.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the threshold of pressure, tactile,and pain thresholds were evaluated after the application of topical Lidocaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iontophoresis of Lidocaine 10% with interferential current (Dynatron 438)</intervention_name>
    <description>drug delivery through interferential current.</description>
    <arm_group_label>lidocaine iontophoresis using interferential current</arm_group_label>
    <other_name>Dynatron 438, Enraf Nonius Comp., Netherlands</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 10% was sprayed at the identified region</intervention_name>
    <arm_group_label>lidocaine</arm_group_label>
    <other_name>Xylocaine 10% spray, AstraZeneca, Korea</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>interferential current</intervention_name>
    <arm_group_label>interferential current</arm_group_label>
    <other_name>Dynatron 438, Enraf Nonius Comp., Netherlands</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy women with age between 18 and 25 years old

        Exclusion Criteria:

          -  Systemic disorders,

          -  neuro-muscular diseases such as diabetes and all forms of neuropathies,

          -  and use of narcoleptic drugs which may contaminate the results.

          -  Also, none of the participants were on their menstrual cycle.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>alireza motealleh, PhD, PT</last_name>
    <role>Study Director</role>
    <affiliation>Shiraz University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Rehabilitation</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <zip>33669-71947</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Başkurt F, Ozcan A, Algun C. Comparison of effects of phonophoresis and iontophoresis of naproxen in the treatment of lateral epicondylitis. Clin Rehabil. 2003 Feb;17(1):96-100.</citation>
    <PMID>12617384</PMID>
  </reference>
  <reference>
    <citation>Ebrahimi S, Abbasnia K, Motealleh A, Kooroshfard N, Kamali F, Ghaffarinezhad F. Effect of lidocaine phonophoresis on sensory blockade: pulsed or continuous mode of therapeutic ultrasound? Physiotherapy. 2012 Mar;98(1):57-63. doi: 10.1016/j.physio.2011.01.009.</citation>
    <PMID>22265386</PMID>
  </reference>
  <reference>
    <citation>Gökoğlu F, Fındıkoğlu G, Yorgancoğlu ZR, Okumuş M, Ceceli E, Kocaoğlu S. Evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome. Am J Phys Med Rehabil. 2005 Feb;84(2):92-6.</citation>
    <PMID>15668556</PMID>
  </reference>
  <reference>
    <citation>Pal B, Morris J. Perceived risks of joint infection following intra-articular corticosteroid injections: a survey of rheumatologists. Clin Rheumatol. 1999;18(3):264-5.</citation>
    <PMID>11206357</PMID>
  </reference>
  <reference>
    <citation>Jadoul A, Bouwstra J, Préat V V. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Deliv Rev. 1999 Jan 4;35(1):89-105.</citation>
    <PMID>10837691</PMID>
  </reference>
  <reference>
    <citation>Jadoul A, Doucet J, Durand D, Preat V. Modifications induced on stratum corneum structure after in vitro iontophoresis; ATR-FTIR and X-ray scattering studies. J. Controlled Release 42: 165-173,1996.</citation>
  </reference>
  <reference>
    <citation>Thysman S, Van Neste D, Préat V. Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol. 1995;8(5):229-36.</citation>
    <PMID>8527154</PMID>
  </reference>
  <reference>
    <citation>Costello CT, Jeske AH. Iontophoresis: applications in transdermal medication delivery. Phys Ther. 1995 Jun;75(6):554-63. Review.</citation>
    <PMID>7770500</PMID>
  </reference>
  <reference>
    <citation>Singh P, Maibach HI. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):161-213. Review.</citation>
    <PMID>7600587</PMID>
  </reference>
  <reference>
    <citation>Panzade P, Puranik P. Iontophoresis: A Functional Approach for Enhancement of Transdermal Drug Delivery. Asian Journal of Biomedical and Pharmaceutical Sciences 2(11): 1-8, 2012.</citation>
  </reference>
  <reference>
    <citation>Banga AK, Chien YW. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res. 1993 May;10(5):697-702.</citation>
    <PMID>8321834</PMID>
  </reference>
  <reference>
    <citation>Gupta SK, Bernstein KJ, Noorduin H, Van Peer A, Sathyan G, Haak R. Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol. 1998 Oct;38(10):951-8.</citation>
    <PMID>9807977</PMID>
  </reference>
  <reference>
    <citation>Lvovich VF, Matthews E, Riga AT, Kaza L. AC electrokinetic platform for iontophoretic transdermal drug delivery. J Control Release. 2010 Jul 14;145(2):134-40. doi: 10.1016/j.jconrel.2010.04.015. Epub 2010 Apr 24.</citation>
    <PMID>20420867</PMID>
  </reference>
  <reference>
    <citation>Reinauer S, Neusser A, Schauf G, Hölzle E. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993 Aug;129(2):166-9.</citation>
    <PMID>7654577</PMID>
  </reference>
  <reference>
    <citation>Ganne JM. Interferential therapy. Aust J Physiother. 1976 Sep;22(3):101-10. doi: 10.1016/S0004-9514(14)61005-9.</citation>
    <PMID>25026222</PMID>
  </reference>
  <reference>
    <citation>Jorge S, Parada CA, Ferreira SH, Tambeli CH. Interferential therapy produces antinociception during application in various models of inflammatory pain. Phys Ther. 2006 Jun;86(6):800-8.</citation>
    <PMID>16737405</PMID>
  </reference>
  <reference>
    <citation>Watson T. The role of electrotherapy in contemporary physiotherapy practice. Man Ther. 2000 Aug;5(3):132-41. Review.</citation>
    <PMID>11034883</PMID>
  </reference>
  <reference>
    <citation>Bhatia G, Banga AK. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride. Biomed Res Int. 2014;2014:537941. doi: 10.1155/2014/537941. Epub 2014 May 15.</citation>
    <PMID>24959580</PMID>
  </reference>
  <reference>
    <citation>Hayashi S, Ogami S, Shibaji T, Umino M. Lidocaine transport through a cellophane membrane by alternating current iontophoresis with a duty cycle. Bioelectrochemistry. 2009 Feb;74(2):315-22. doi: 10.1016/j.bioelechem.2008.11.007. Epub 2008 Nov 30.</citation>
    <PMID>19110474</PMID>
  </reference>
  <reference>
    <citation>Yan G, Xu Q, Anissimov YG, Hao J, Higuchi WI, Li SK. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude. Pharm Res. 2008 Mar;25(3):616-24. Epub 2007 Aug 17.</citation>
    <PMID>17703345</PMID>
  </reference>
  <reference>
    <citation>Yamazaki Y, Umino M, Fukayama H, Shimada M. The effect of alternating current iontophoresis on rats with the chronic constriction injury to the infraorbital nerve. Int J Dent. 2012;2012:405292. doi: 10.1155/2012/405292. Epub 2012 May 23.</citation>
    <PMID>22675357</PMID>
  </reference>
  <reference>
    <citation>Kandell ER, Schwartz JH, Jessell TM. Principles of neural science 2000. 4th edition.</citation>
  </reference>
  <results_reference>
    <citation>Viscusi ER, Witkowski TA. Iontophoresis: the process behind noninvasive drug delivery. Reg Anesth Pain Med. 2005 May-Jun;30(3):292-4.</citation>
    <PMID>15898033</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>July 1, 2015</last_update_submitted>
  <last_update_submitted_qc>July 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Alireza Motealleh</investigator_full_name>
    <investigator_title>Dr. Amin Kordi Yoosefinejad</investigator_title>
  </responsible_party>
  <keyword>Drug Delivery</keyword>
  <keyword>Iontophoresis</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Pressure</keyword>
  <keyword>Tactile perception</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

